Factors associated with depression and anxiety among patients attending community-based methadone maintenance treatment in China

Addiction

Volumn 110, Issue S1, 2015, Pages 51-60

  Yin, Wenyuan ^a   Pang, Lin ^a   Cao, Xiaobin ^a   Mcgoogan, Jennifer M ^a   Liu, Michael ^a   Zhang, Congbin ^b   Li, Zhijun ^c   Li, Jianhua ^b   Rou, Keming ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Yunnan Institute of Drug Abuse   (China)

^c CDC Global AIDS Program   (China)

Author keywords

Anxiety; Depression; Drug user; Methadone maintenance treatment; Zung's Self Rating

Indexed keywords

METHADONE; NARCOTIC ANALGESIC AGENT;

ADULT; ANXIETY; CHINA; COMORBIDITY; CROSS-SECTIONAL STUDY; DEPRESSION; DRUG DEPENDENCE TREATMENT; DRUG USE; FEMALE; HUMAN; MALE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREVALENCE; PSYCHOLOGY; QUESTIONNAIRE; RISK FACTOR; SELF REPORT; URINE; YOUNG ADULT;

ADULT; ANALGESICS, OPIOID; ANXIETY; CHINA; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSION; DRUG USERS; FEMALE; HUMANS; MALE; METHADONE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREVALENCE; RISK FACTORS; SELF REPORT; SUBSTANCE ABUSE TREATMENT CENTERS; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84919682905     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12780     Document Type: Article

References (33)

1. The United Nations Theme Group on HIV/AIDS in China. China's Titanic Peril: 2001 Update of the AIDS Situation and Needs Assessment Report. Beijing: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2002.
2. Pang L., Hao Y., Mi G., Wang C., Luo W., Rou K. etal. Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS 2007; 21: S103-S107.
3. Yin W., Hao Y., Sun X., Gong X., Li F., Li J. etal. Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int J Epidemiol 2010; 39: ii29-37.
4. Li L., Lin C., Wan D., Zhang L., Lai W. Concurrent heroin use among methadone maintenance clients in China. Addict Behav 2012; 37: 264-268.
5. National Center for AIDS/STD Control and Prevention, Chinese Center for Diseases Control and Prevetion. 2012 China National HIV/AIDS Program Implementation Report. Beijing, January, 2013.
6. Ministry of Health of the People's Republic of China, Joint United Nations Program on HIV/AIDS, and World Health Organization. 2011 Estimates for the HIV/AIDS Epidemic in China. Beijing, China, 2011.
7. Yang Y. C., Duan S., Xiang L. F., Ye R., Gao J., Yang S. etal. Adherence and related determinants on methadone maintenance treatment among heroin addicts in Dehong prefecture, Yunnan province. Zhonghua Liu Xing Bing Xue Za Zhi 2011; 32: 125-129.
8. Lin C., Wu Z., Detels R. Family support, quality of life and concurrent substance use among methadone maintenance therapy clients in China. Public Health 2011; 125: 269-274.
9. Veilleux J. C., Colvin P. J., Anderson J., York C., Heinz A. J. A review of opioid dependence treatment: pharmacological and psychosocial interventions to treat opioid addiction. Clin Psychol Rev 2010; 30: 155-166.
10. Senbanjo R., Wolff K., Marshall E. J., Strang J. Persistence of heroin use despite methadone maintenance treatment: poor coping self-efficacy predicts continued heroin use. Drug Alcohol Rev 2009; 28: 608-615.
11. Grella C. E., Karno M. P., Warda U. S., Niv N., Moore A. A. Gender and comorbidity among individuals with opioid use disorders in the NESARC study. Addict Behav 2009; 34: 498-504.
12. Conner K. R., Pinquart M., Duberstein P. R. Meta-analysis of depression and substance use and impairment among intravenous drug users (IDUs). Addiction 2008; 103: 524-534.
13. Carpentier P. J., Krabbe P. F., van Gogh M. T., Knapen L. J., Buitelaar J. K., de Jong C. A. Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. Am J Addict 2009; 18: 470-480.
14. Soyka M., Kranzler H. R., van den Brink W., Krystal J., Möller H. J., Kasper S. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance abuse disorders. Part 2: opioid dependence. World J Biol Psychiatry 2011; 12: 160-187.
15. Fatséas M., Denis C., Lavie E., Auriacombe M. Relationship between anxiety disorders and opiate dependence-a systemic review of the literature: implications for diagnosis and treatment. J Subst Abuse Treat 2010; 38: 220-230.
16. Cleary M., Hunt G., Matheson S., Siegfried N., Walter G. Psychosocial interventions for people with both severe mental illness and substance abuse. Cochrane Database Syst Rev 2008 Jan 23; (1): CD001088.
17. Ngo H. T., Tait R. J., Hulse G. K. Hospital psychiatric comorbidity and its role in heroin dependence treatment outcomes using naltrexone implant or methadone maintenance. J Psychopharmacol 2011; 25: 774-782.
18. Peles E., Schreiber S., Naumovsky Y., Adelson M. Depression in methadone maintenance treatment patients: rate and risk factors. J Affect Disord 2007; 99: 213-220.
19. Liu Y., Wang Q., Zhang J. B., Zhou W. H. A clinical survey on common complications in heroin addicts and intervention strategies. Chin J Drug Abuse Prev Treat 2011; 1: 1-4.
20. Gao Q., Cheng H., Ding L., Pan X. W., Wang B. Psycho-social epidemiological survey of female heroin addicts receiving methadone maintenance treatment. Chin J AIDS STD 2009; 1: 15-17.
21. Tian W. C., Feng J. C., Li X., Peng Y., Hou J. Survey of depression and causes in patients with methadone maintenance treatment. Chin J Drug Abuse Prev Treat 2009; 4: 195-198.
22. Chinese Society of Psychiatry. Chinese Classification of Mental Disorder (CCMD-3)(3rd version). Beijing: People's Medical Publishing House; 2001.
23. Zung W. W. A self-rating depression scale. Arch Gen Psychiatry 1965; 12: 63-70.
24. Zung W. W. A rating instrument for anxiety disorders. Psychosomatics 1971; 12: 371-379.
25. Zhang M. Y. Psychiatric Rating Scale Assessment Manual [M]. The Second Version. Changsha: Hunan Science and Technical Publishing House; 2003, pp. 25-43.
26. Shu L. A self-rating depression scale. Chin Ment Health J 1999; 1: 194-196.
27. Wu WY. A self-rating anxiety scale. Chin Ment Health J 1999; 1: 235-238.
28. Zhou C. Y., Dai W. H., Song H. B., Huang X. W. The effect of comprehensive intervention on psychologic status in the patients with methadone maintenance therapy. Chin J Drug Abuse Prev Treat 2010; 3: 145-148.
29. Xu J. X., Wang D. P., Hu W. S. Duloxetine for depression and anxiety of heroin dependence. Chin J Drug Abuse Prev Treat 2011; 1: 11-13.
30. Cao X. B., Yin W. Y., Pang L. Zhang C., Xu J., Xiao Y. etal. Risk factors which were associated with heroin use during the methadone maintenance treatment among 1301 patients in 9 cities of China. Zhonghua Liu Xing Bing Xue Za Zhi 2010; 31: 269-272.
31. National Institutes of Health (NIH) Consensus Conference. Effective medical treatment of opiate addiction. JAMA 1998; 280: 1936-1943.
32. Fareed A., Casarella J., Amar R., Vavalapalli S., Drexler K. Methadone maintenance dosing guideline for opioid dependence, a literature review. J Addict Dis 2010; 29: 1-14.
33. Lin C., Detels R. A qualitative study exploring the reason for low dosage of methadone prescribed in the MMT clinics in China. Drug Alcohol Depend 2011; 117: 45-49.